CClinicalTrials.gg
CompletedNCT00824876Updated Jul 8, 2009

Orthostatic Tolerance in Mamma Cancer Patients After Anaesthesia

An observational study in Breast Cancer, sponsored by Rigshospitalet, Denmark. Completed at 1 site in Denmark. Open to female participants aged 18 Months to 70 Years. Per ClinicalTrials.gov, last updated 2009-07-08.

Sponsored by Rigshospitalet, Denmark · Observational

Study type
Observational
Time perspective
Prospective
Ages
18 Months to 70 Years
Sex
Female
01

Study summary

The investigators want to investigate the effect of anaesthesia, on the ability to maintain upright posture immediately after surgery in mamma cancer patients.

The investigators hypothesis is, that a standard anaesthesia does not effect the ability to maintain upright posture right after surgery.

Read the detailed description

It is known, that patients undergoing major surgery have problems maintaining upright posture after major surgery. This can be due to fall in bloodpressure, with symptoms like dizziness, nausea/vomiting and fainting.

With this investigation, we want to prove that anaesthesia is not the decisive factor, in patients ability to maintain upright posture after surgery.

02

Conditions studied

  • Breast Cancer

Keywords

  • Mammae cancer patients
03

In context

Lead sponsor

Rigshospitalet, Denmark is the lead sponsor of 1,017 studies on the registry; 183 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Months to 70 Years
Sexes eligible
Female
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Mammasurgery patients

Inclusion criteria

  • Patients having performed elective breast surgery
  • Age between 18 and 70 years
  • Patients who have given written consent to participate in the project after haven completely understood the contents and limitations of the protocol

Exclusion criteria

Exclusion Criteria:

  • Patients who do not understand or speak Danish
  • Patients who have not signed the informed consent or the written authority pre-medication, except 1g paracetamol
  • ASA > II
  • Pregnant or breastfeeding
  • Known to have Renal disease
  • Known to have Psychiatric disorder (not considering the use of SSRI antidepressive)
  • Need for crash induction or prone position
  • Oesophageal varicoses
  • Necrosis or cancer in: Mouth, Pharynx, Larynx or Oesophagus
  • Coarctation or aneurism in the proximal Aorta
  • Severe bleeding disease
05

Study design

Time perspective
Prospective
06

What researchers measure

Primary outcomes

  1. To investigate orthostatic function, measured by Finapress

Secondary outcomes

  1. To investigate the occurrence of postsurgery nausea/vomiting

07

Study locations

1 site
  • Dept of anesthesia 2041, ABD centre, Rigshospitalet, Blegdamsvej
    Copenhagen, Denmark
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 8, 2009, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00824876
Lead sponsor
Rigshospitalet, Denmark
First posted
Jan 19, 2009
Start date
Jan 2009
Last update
Jul 8, 2009

Study contacts

Henrik Kehlet, MD, Ph.D
study director · dept of surgical patophysiology

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2009. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion